HPV Vaccines Market Analysis | 2023-2028

Market Insights

The HPV vaccines market was estimated at USD 6.51 billion in 2022 and is likely to grow at a CAGR of 16.05% during 2023-2028 to reach USD 15.94 billion in 2028.

Want to know more about the market scope? Register Here

Market Dynamics

Introduction

HPV infection is one of the most common sexually transmitted infections which is caused by HPV-related cancers, such as genital and cervical cancers. HPV infection vaccines are primarily used to prevent genital warts, cervical cancer, anal cancer, and vaginal cancer. Three commercially available HPV prevention vaccines, such as Gardasil 9 and Gardasil by Merck and Cervarix developed by GSK Plc, are known to be highly effective in preventing HPV infection and genital precancerous lesions.

COVID-19 IMPACT

The outbreak of the COVID-19 virus had a devastating impact on the HPV vaccine industry. The healthcare industry is currently facing major challenges as it is unable to provide proper medical facilities to cater to the ever-growing coronavirus patient pool. With the stringent imposition of lockdown and social distance regulations, there were limited check-ups of women suffering from sexually transmitted diseases. During the pandemic period in 2020, around 342,000 women lost their lives due to cervical cancer. Thus, a poor healthcare system due to limited medical professionals and funding affected the market growth.

Market Drivers

The rising prevalence of cervical cancer among women is a prime factor augmenting the demand for HPV vaccines.

• Moreover, the growing need to reduce HPV infections further adds emphasis to the market growth in the near future.
• Furthermore, the government bodies in numerous countries are focusing on imposing stringent policies for supplying vaccines to prevent the burden of this disease, thus boosting the product demand.
• However, these vaccines are short in supply and are available in limited amounts thus failing to cater to the rising need, thus affecting the market expansion.

Key Players

Key players operating in the market are-

• Lumetrics (The U.S),
• Marco (The U.S),
• Voptica (Spain),
• AMICO GROUP (UAE),
• NIDEK (Japan),
• Hanson Instruments (UK),
• Alcon (Switzerland), Carl Zeiss (Germany),
• Essilor (France), and Johnson & Johnson Visioncare Inc. (US).

Note: The above list does not necessarily include all the top players in the market.

Are you the leading player in this market? We would love to include your name. Write to us at sales@stratviewresearch.com

Segment Analysis

By Type

By type, the HPV vaccines market has been bifurcated into bivalent, polyvalent.

• Under these, the polyvalent segment accounted for the highest market share in 2022 and is projected to grow at a moderate CAGR in the coming years.
• This is mainly attributed to their low cost and performance efficiency and that they are highly popular, especially in the developing countries of Asia Pacific, thus bolstering the segment growth.

Regional Insights

By region, the North American market witnessed the highest market share in 2022 and is estimated to register at a considerable CAGR during the review period. This is mainly attributed to the strong presence of well-established healthcare facilities, along with the ease in the availability of necessary resources. Moreover, people are aware of the presence of vaccines and related therapeutic procedures, thus augmenting the for vaccination and treatment, further boosting regional growth.

Know the high-growth countries in this report. Register Here

Research Methodology

• This strategic assessment report from Stratview Research provides a comprehensive analysis that reflects HPV vaccines market realities and future market possibilities for the forecast period.
• The report segments and analyzes the market in the most detailed manner in order to provide a panoramic view of the market.
• The vital data/information provided in the report can play a crucial role for market participants as well as investors in the identification of the low-hanging fruits available in the market as well as to formulate growth strategies to expedite their growth process.
• This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.
• More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles, have been leveraged to gather the data.
• We conducted more than 15 detailed primary interviews with market players across the value chain in all four regions and industry experts to obtain both qualitative and quantitative insights.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into market dynamics and will enable strategic decision-making for existing market players as well as those willing to enter the market. The following are the key features of the report:

• Market structure: Overview, industry life cycle analysis, supply chain analysis.
• Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis.
• Market trend and forecast analysis.
• Market segment trend and forecast.
• Competitive landscape and dynamics: Market share, Service portfolio, New Product Launches, etc.
• COVID-19 impact and its recovery curve
• Attractive market segments and associated growth opportunities.
• Emerging trends.
• Strategic growth opportunities for the existing and new players.
• Key success factors.

Market Segmentation

This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

The HPV vaccines market is segmented into the following categories:

By Type

• Bivalent
• Polyvalent

By Indication Type

• Cervical Cancer
• Anal Cancer
• Penile Cancer
• Oropharyngeal Cancer
• Genital Warts
• Others

By Distribution Channel Type

• Hospital & Retail Pharmacies
• Government Suppliers
• Others

By Region

• North America (Country Analysis: the USA, Canada, and Mexico)
• Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and the Rest of Europe)
• Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and the Rest of Asia-Pacific)
• Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

Want to know the most attractive market segments? Click Here

Report Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

Company Profiling

• Detailed profiling of additional market players (up to 3 players)
• SWOT analysis of key players (up to 3 players)

Market Segmentation

• Current market segmentation is by any one of the types and by distribution channel type.

Competitive Benchmarking

• Benchmarking of key players on the following parameters: product portfolio, geographical reach, regional presence, and strategic alliances.

Custom Research: Stratview Research offers custom research services across sectors. In case you need any custom research requirements related to market assessment, competitive benchmarking, sourcing and procurement, target screening, or other requirements, please send your inquiry to sales@stratviewresearch.com.